Author | Roger W. Byhardt, MD

Articles

Toxicities in RTOG Combined-Modality Trials for Inoperable Non–Small-Cell Lung Cancer

October 01, 1999

Inoperable non–small-cell lung cancer has become the domain of combined-modality treatment based on several recent, large, phase III studies. Results of Radiation Therapy Oncology Group (RTOG) phase II studies have